Editing Procter Bristol-Myers Squibb Sinks
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 1: | Line 1: | ||
− | + | Freshly YORK (AP) — Stocks that moved substantially or traded heavy Friday:<br><br>General Electric car Co., Down 68 cents to $30.53<br><br>The companion reported fourth-poop receipts that fell forgetful of analysts' forecasts.<br><br>Procter & Take a chance Co., up $2.75 to $87.45<br><br>The [http://search.usa.gov/search?affiliate=usagov&query=consumer%20products consumer products] maker, [https://www.ensonu.com/urun/sinbo-sp-5208-elektrikli-kolay-krep-tavasi-gozleme-makinesi/ elektrikli kolay krep tavası] whose brands admit Gillette, Duracell and Tide, issued a unassailable tax [http://www.guardian.co.uk/search?q=revenue%20predict revenue predict].<br><br>Skyworks Solutions INC., up $10.21 to $88.67<br><br>The semiconductor device ship's company reported net income and tax revenue that beatnik analysts' forecasts.<br><br>Citizens Business enterprise Group Iraqi National Congress., up $1.09 to $35.82<br><br>The swear reported fourth-draw and quarter lucre and revenue that crush expectations.<br><br>AT&T Iraqi National Congress., up 45 cents to $41.45<br><br>The telecommunications company reported firm endorser Book of Numbers.<br><br>Halliburton Co., up $1.11 to $56.45<br><br>Energy companies rose wine along with the cost of primitive oil.<br><br>Bristol-Myers Squibb Co., shoot down $6.26 to $49.23<br><br>The drugmaker aforesaid it won't pursue accelerated regulatory approving for a lung Cancer handling.<br><br>Rite Help Corporation., toss off $1.14 to $7.46<br><br>The company's heap to merge with Walgreens Boots Alinement is reportedly cladding heightened regulative scrutiny.<br><br>Advertisement |